The rapid emergence of antibiotic-resistant bacterial strains has prompted efforts to find new and more efficacious treatment strategies. Targeting virulence factors produced by pathogenic bacteria has gained particular attention in the last few years. One of the inherent advantages of this approach is that it provides less selective pressure for the development of resistance mechanisms. In addition, antivirulence drugs could potentially be the answer for diseases in which the use of conventional antibiotics is counterproductive. That is the case for bacterial toxin-mediated diseases, in which the severity of the symptoms is a consequence of the exotoxins produced by the pathogen. Examples of these are haemolytic-uraemic syndrome produced by Shiga toxins, the profuse and dangerous dehydration caused by Cholera toxin or the life-threatening colitis occasioned by clostridial toxins. This review focuses on the recent advances on the development of small molecules with antitoxin activity against Enterohaemorrhagic Escherichia coli, Vibrio cholerae and Clostridium difficile given their epidemiological importance. The present work includes studies of small molecules with antitoxin properties that act directly on the toxin (direct inhibitors) or that act by preventing expression of the toxin (indirect inhibitors).
-
Cover Image
Cover Image
Three derivatives of one Streptomyces species showing variations in morphological development and pigment production. In this issue, Rebecca Devine, Matthew Hutchings and Neil Holmes explore how the use of new technologies, including improved culture-dependent and -independent techniques, combined with searching underexplored environments, promises to identify a new generation of antibiotics from actinomycete bacteria such as Streptomyces. See pages 1–12 for further details. Image kindly provided by Paul A. Hoskisson (University of Strathclyde, UK).
Disarming the enemy: targeting bacterial toxins with small molecules
Daniel Walker, Alejandro Huerta-Uribe, Andrew J. Roe; Disarming the enemy: targeting bacterial toxins with small molecules. Emerg Top Life Sci 21 April 2017; 1 (1): 31–39. doi: https://doi.org/10.1042/ETLS20160013
Download citation file:
Sign in
Sign in to your personal account
Captcha Validation Error. Please try again.